Theranos Founder Elizabeth Holmes Has Been Found Guilty of 4 Fraud-Related Charges After a Months-Long Federal TrialHer trial spanned 4 months and featured bombshell testimony from investors, ex-employees, and Holmes herself.

Elizabeth Holmes has been convicted on multiple counts after a months-long federal fraud trial.

TheTheranos founder被判三个项电信欺诈和one count of conspiracy to commit wire fraud on Monday. She was found not guilty on four other counts, and jurors were unable to reach a unanimous verdict on the remaining three counts against her.

The four counts for which Holmes was convicted include one count of conspiracy to defraud investors and three counts of wire fraud related to investments made by hedge fund managerBrian Grossman,theDeVos family,and former Cravath attorneyDaniel Mosley.

Holmes was acquitted of all counts related topatients who took Theranos tests.

Related:Former Theranos CEO Elizabeth Holmes Admits to Inaccuracies in Her First Major Cover Story

The three counts that deadlocked the jury were for wire fraud in connection with investments made by Black Diamond Ventures founderChris Lucas,former money manager and financial plannerAlan Eisenman, andBryan Tolbert,who is vice president of finance at investment firm Hall Group.

The mixed verdict arrived on the jurors' seventh day of deliberations, just hours after theytold the court they were deadlocked on three countsand were subsequently instructed by the judge to keep deliberating.

Holmes waschargedwith nine counts of wire fraud and two counts of conspiracy to commit wire fraud. The Justice Department alleged that Holmes andRamesh "Sunny" Balwani,Theranos' former president and COO,schemed to defraud investors, doctors, and patients by making false claims about Theranos' technological abilities and finances and by hiding information about issues with the company's blood-testing machines.

Each count carried with it a maximum 20-year prison sentence, a $250,000 fine, and a requirement to pay restitution.

In recent weeks, investors, patients, doctors, and ex-Theranos employees took the stand against the one-time Silicon Valley superstar.

Prosecutors in Holmes' casecalled 29 witnesses to testify over the course of 11 weeks. Among them were ex-Theranos employees who said theysounded the alarm on testing issues to no avail,former investors and board members who described being wooed by claims they now know to be false, and Theranos patients whorecounted inaccurate test results.

The defense called surprisingly few witnesses, largely leaning ontestimony from Holmes herself,who was their last of just three witnesses, to make their case.

On the stand for seven days, Holmes frequently deflected blame in her testimony, saying that she relied on Balwani, lab staff, and others for information about Theranos and that she had no reason to doubt them when they frequently reported good news about the company.

Still, Holmes made several key admissions.

She acknowledged that sheadded logos from Pfizer, GSK, and Schering-Plough to company reportswithout authorization but said no one from the pharmaceutical firms later objected or told her to remove the logos. Holmesadmitted to hiding Theranos' use of modified third-party devicesbut said she did so because she considered the modifications trade secrets and wanted to protect them accordingly. She conceded that she tried to kill The Wall Street Journal's exposé on the company, again leaning onher trade secret defense.

Holmes alsoexpressed regrets for some actions,including Theranos' handling of whistleblower Erika Cheung's claims and her approach to a Fortune article that helped catapult Holmes to fame but contained multiple inaccuracies.

Holmes dropped out of Stanford at 19 to build Theranos. The company was valued at $9 billion at its peak, earning Holmes recognition as the world's youngest self-made female billionaire in 2015. It was hailed as a revolutionary force in healthcare and counted former senators, US secretaries of defense, and billionaire CEOs among itsinvestors and board members.

Theranos' public downfall kicked off in 2015, when a Wall Street Journalinvestigationfound Theranos couldn't perform nearly as many tests as advertised and relied heavily on third-party devices, not its proprietary ones. The startup shut down in 2018.

The Theranos saga has exposed the most extreme repercussions of Silicon Valley's "fake it till you make it" culture, shone a light on holes in the traditional due diligence process, and challenged the girlboss feminism for which Holmes was a poster child.

Balwani's trial will begin in February.